An in-depth look to PHARMGEN SCIENCE operating, investing, and financing activities

004720 free cash flow for Q2 24 is -1.16 B KRW. For 2023, 004720 free cash flow was 3.17 B KRW and operating cash flow was 5.44 B KRW.